Gao Ying, Chen Min, Ye Hua, Guo Xiao-Hui, Zhao Ming-Hui, Wang Hai-Yan
Department of Nephrology, Peking University First Hospital, Beijing 100034, PR China.
Int Immunopharmacol. 2007 Jan;7(1):55-60. doi: 10.1016/j.intimp.2006.07.033. Epub 2006 Sep 11.
Antineutrophil cytoplasmic antibody (ANCA) has been well documented in association with propylthiouracil (PTU), and some patients with PTU-induced ANCA also develop clinical vasculitis. The aim of the current study was to detect ANCA specificities in sera from patients with PTU-induced ANCA with and without clinical vasculitis.
Sera from 65 patients with PTU-induced ANCA were collected, and 27 of these patients were diagnosed with PTU-induced ANCA associated systemic vasculitis (AASV). Indirect immunofluorescence assay and antigen-specific ELISAs were used to detect ANCA and their antigen specificities. The seven known target antigens included myeloperoxidase (MPO), proteinase 3, human leukocyte elastase, lactoferrin, cathepsin G, azurocidin and bactericidal/permeability-increasing protein (BPI).
In IIF assay, P-ANCA was found in 58/65 (89.2%) sera, C-ANCA in two, both P-ANCA and C-ANCA in five, respectively. MPO (60%) and lactoferrin (63.1%) were the two most common target antigens detected in sera from all the patients. 25/27 sera from patients with PTU-induced AASV recognized multiple target antigens, which was significantly higher than those (13/38) from patients without (P<0.001). Except anti-BPI antibodies, the prevalence of antibodies against the other six target antigens was significantly higher in patients with clinical vasculitis than that in patients without (P<0.05, respectively).
Antibodies against multiple ANCA specific antigens, especially the antigens rather than MPO and PR3, might be the characteristic of PTU-induced ANCA. Patients with antibodies against more ANCA specific antigens might be at increased risk of developing overt clinical vasculitis. The mechanism of ANCA production in PTU-induced cases was different from that in primary AASV.
抗中性粒细胞胞浆抗体(ANCA)与丙硫氧嘧啶(PTU)相关已得到充分证实,一些PTU诱导的ANCA患者也会出现临床血管炎。本研究的目的是检测PTU诱导的ANCA患者血清中有无临床血管炎时ANCA的特异性。
收集65例PTU诱导的ANCA患者的血清,其中27例被诊断为PTU诱导的ANCA相关系统性血管炎(AASV)。采用间接免疫荧光法和抗原特异性酶联免疫吸附试验检测ANCA及其抗原特异性。七种已知靶抗原包括髓过氧化物酶(MPO)、蛋白酶3、人白细胞弹性蛋白酶、乳铁蛋白、组织蛋白酶G、天青杀素和杀菌/通透性增加蛋白(BPI)。
在IIF试验中,58/65(89.2%)份血清中发现P-ANCA,2份血清中发现C-ANCA,5份血清中同时发现P-ANCA和C-ANCA。MPO(60%)和乳铁蛋白(63.1%)是所有患者血清中检测到的两种最常见靶抗原。27例PTU诱导的AASV患者中有25/27份血清识别多种靶抗原,显著高于无血管炎患者(13/38)(P<0.001)。除抗BPI抗体外,临床血管炎患者中针对其他六种靶抗原的抗体患病率显著高于无血管炎患者(分别为P<0.05)。
针对多种ANCA特异性抗原的抗体,尤其是除MPO和PR3以外的抗原,可能是PTU诱导的ANCA的特征。针对更多ANCA特异性抗原的抗体的患者发生明显临床血管炎的风险可能增加。PTU诱导病例中ANCA产生的机制与原发性AASV不同。